American CryoStem Corporation
CRYO · OTC
9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -96.3% | 73.5% | -70.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 34.1% | 92.1% | 90.1% | 73.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -10,513.2% | -93.4% | -282.4% | -110% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -13,985.4% | -211.4% | -336.5% | -135.1% |
| EPS Diluted | -0.05 | -0.02 | -0.02 | -0.03 |
| % Growth | -149.5% | 0% | 33.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |